TD Cowen analyst Yaron Weber maintains Amgen (NASDAQ:AMGN) with a Buy and lowers the price target from $370 to $360.
TD Cowen Maintains Buy on Amgen, Lowers Price Target to $360
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.